2019
DOI: 10.1016/j.scr.2019.101618
|View full text |Cite
|
Sign up to set email alerts
|

Generation of human induced pluripotent stem cell line carrying SCN5AC2204>T Brugada mutation (MUSli009-A-1) introduced by CRISPR/Cas9-mediated genome editing

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2021
2021
2023
2023

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(1 citation statement)
references
References 4 publications
0
1
0
Order By: Relevance
“…However, HiPSC-derived myocytes from patients with defined mutations using VARRÓ ET AL. 1116 Physiol Rev VOL 101 JULY 2021 www.prv.org CRISPR/Cas9-edited cells can mimic diseases (688,(695)(696)(697)(698) that are often hard or impossible to recreate properly in animal experiments. Recent efforts to culture and continuously pace HiPSC-derived cardiomyocytes cultured in collagen gels as "engineered heart tissue" represent a new two-dimensional (2-D) and threedimensional (3-D) approach (699-701), since it resembles more the mature myocardium.…”
Section: Species-dependent Differences In Action Potentialsmentioning
confidence: 99%
“…However, HiPSC-derived myocytes from patients with defined mutations using VARRÓ ET AL. 1116 Physiol Rev VOL 101 JULY 2021 www.prv.org CRISPR/Cas9-edited cells can mimic diseases (688,(695)(696)(697)(698) that are often hard or impossible to recreate properly in animal experiments. Recent efforts to culture and continuously pace HiPSC-derived cardiomyocytes cultured in collagen gels as "engineered heart tissue" represent a new two-dimensional (2-D) and threedimensional (3-D) approach (699-701), since it resembles more the mature myocardium.…”
Section: Species-dependent Differences In Action Potentialsmentioning
confidence: 99%